FI934300L - Bradykininantagonister - Google Patents

Bradykininantagonister Download PDF

Info

Publication number
FI934300L
FI934300L FI934300A FI934300A FI934300L FI 934300 L FI934300 L FI 934300L FI 934300 A FI934300 A FI 934300A FI 934300 A FI934300 A FI 934300A FI 934300 L FI934300 L FI 934300L
Authority
FI
Finland
Prior art keywords
bradykinin antagonist
bradykinin
antagonist
Prior art date
Application number
FI934300A
Other languages
English (en)
Finnish (fi)
Other versions
FI934300A7 (fi
FI934300A0 (fi
Inventor
John C Cheronis
James K Blodgett
Eric T Whalley
Shadrach R Eubanks
Lisa Gay Allen
Khe Thanh Nguyen
Original Assignee
Cortech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortech Inc filed Critical Cortech Inc
Publication of FI934300A0 publication Critical patent/FI934300A0/fi
Publication of FI934300A7 publication Critical patent/FI934300A7/fi
Publication of FI934300L publication Critical patent/FI934300L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/816—Attached to the carrier via a bridging agent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI934300A 1991-04-01 1992-03-30 Bradykininantagonister FI934300L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67739191A 1991-04-01 1991-04-01
US85958292A 1992-03-27 1992-03-27
PCT/US1992/002431 WO1992017201A1 (en) 1991-04-01 1992-03-30 Bradykinin antagonists

Publications (3)

Publication Number Publication Date
FI934300A0 FI934300A0 (fi) 1993-09-30
FI934300A7 FI934300A7 (fi) 1993-10-20
FI934300L true FI934300L (fi) 1993-10-20

Family

ID=27101779

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934300A FI934300L (fi) 1991-04-01 1992-03-30 Bradykininantagonister

Country Status (10)

Country Link
US (2) US5620958A (cs)
EP (1) EP0586613A4 (cs)
JP (1) JPH06508116A (cs)
AU (1) AU660683B2 (cs)
CA (1) CA2106677A1 (cs)
CZ (1) CZ203693A3 (cs)
FI (1) FI934300L (cs)
HU (1) HUT65328A (cs)
SK (1) SK106193A3 (cs)
WO (1) WO1992017201A1 (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
JP3576554B2 (ja) * 1993-09-21 2004-10-13 協和醗酵工業株式会社 新規ペプチド
US6872803B1 (en) 1993-09-21 2005-03-29 Kyowa Hakko Kogyo Co., Ltd. Peptides
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
WO1996039425A2 (en) * 1995-06-05 1996-12-12 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
ATE235912T1 (de) * 1995-06-09 2003-04-15 Univ Michigan Bradikininanaloge als selektive thrombininhibitoren
US5849863A (en) * 1995-09-08 1998-12-15 University Of Colorado Cytolytic bradykinin antagonists
US5798388A (en) * 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
SE9601901D0 (sv) * 1996-05-20 1996-05-20 Lars Bjoerck Quinine antagonists for use as a pharmaceutical
DE19642289A1 (de) 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6242210B1 (en) * 1997-05-20 2001-06-05 Actinova Limited Treatment of bacterial infections
US6388054B1 (en) 1998-08-20 2002-05-14 John M. Stewart Anti-cancer compounds
FR2790260B1 (fr) 1999-02-26 2001-05-04 Fournier Ind & Sante Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
WO2000051623A2 (en) 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
US6849605B1 (en) 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US7704958B1 (en) 1999-03-05 2010-04-27 Bio Holding, Inc. Methods and compositions for inhibiting apoptosis using serine protease inhibitors
US7427496B2 (en) * 1999-06-25 2008-09-23 The Regents Of The University Of Colorado Anti-cancer compounds
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US6699486B1 (en) 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
JPWO2003040133A1 (ja) * 2001-11-06 2005-03-03 横浜ゴム株式会社 マレイン酸誘導体およびそれを含む硬化性組成物
DE60327512D1 (de) * 2002-02-04 2009-06-18 Salpep Biotechnology Inc Dipeptide und tripeptide mit anti-inflammatorischer wirkung
US7211566B2 (en) * 2003-04-01 2007-05-01 Universite De Sherbrooke Selective bradykinin (BK) B1 peptidic receptor antagonists and uses thereof
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
US7932228B2 (en) * 2004-08-19 2011-04-26 Societe de Commercialisation des Produits de la Recherche Applique Socpra Sciences Sante et Humaines S.E.C. Method of treating bone or prostate cancer with selective bradykinin B1 receptor antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE150199C (cs) *
US3880823A (en) * 1966-09-16 1975-04-29 Toyo Jozo Kk Process for preparing peptides using N-hydroxy succinimide mono-and dichloroacetate esters
IL47468A (en) * 1975-06-12 1979-05-31 Rehovot Res Prod Process for the cross-linking of proteins using water soluble cross-linking agents
US4618598A (en) * 1982-04-12 1986-10-21 Duke University Method of regulating hormone function or release
US4894443A (en) * 1984-02-08 1990-01-16 Cetus Corporation Toxin conjugates
FR2566271B1 (fr) * 1984-06-20 1986-11-07 Sanofi Sa Nouveaux conjugues cytotoxiques utilisables en therapeutique et procede d'obtention
US4882346A (en) * 1987-06-16 1989-11-21 The United States Of America As Reprsented By The Department Of Health And Human Services Chemical differentiating agents
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
US5416191A (en) * 1991-04-01 1995-05-16 Cortech, Inc. Bradykinin antagonists

Also Published As

Publication number Publication date
FI934300A7 (fi) 1993-10-20
FI934300A0 (fi) 1993-09-30
US5635593A (en) 1997-06-03
CZ203693A3 (en) 1994-07-13
JPH06508116A (ja) 1994-09-14
EP0586613A1 (en) 1994-03-16
EP0586613A4 (en) 1994-08-24
AU660683B2 (en) 1995-07-06
WO1992017201A1 (en) 1992-10-15
US5620958A (en) 1997-04-15
HU9302780D0 (en) 1993-12-28
CA2106677A1 (en) 1992-10-02
SK106193A3 (en) 1994-05-11
HUT65328A (en) 1994-05-02
AU1875192A (en) 1992-11-02

Similar Documents

Publication Publication Date Title
FI934300L (fi) Bradykininantagonister
FI924405A7 (fi) Lhrh-antagonister
ATE137279T1 (de) Stoffauflauf
ITTO910654A0 (it) Antagonisti della bradichinina
ATA131391A (de) Reibring
FI910493A7 (fi) Sulkupuomi
FI921576L (fi) Kolecystokininantagonister
FI933156A7 (fi) Lhrh-antagonister
ATA11391A (de) Beschlag
FI953646L (fi) Oksitosiiniantaginisti
ATA170491A (de) Mauerstein
ATA39792A (de) Maehwerk
NO305649B1 (no) Silot°mmeanordning
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
ATA67791A (de) Rollski
FI925218A0 (fi) Distansbaoge foer isolerfoerglasningar
ATA9892A (de) Formstein
KR930002091U (ko) 세면기 설치대
BR9101719A (pt) Barreira
KR930001831U (ko) 포획구
DK200391D0 (da) Special soem
KR930002787U (ko) 구축용 조립블록
BR7101342U (pt) Hamburgueira
BR7102405U (pt) Chutegol
ATA23591A (de) Muenzkassa

Legal Events

Date Code Title Description
FD Application lapsed